Unknown
Who we are
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
Proton Therapy in the Treatment of Liver Metastases
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
LT for Unresectable Colorectal Liver Metastasis
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
